-transparent.png){kind=logo}
Di-(2-ethylhexyl)phthalate (DEHP) taken orally by two volunteers (30 mg each) was excreted in the urine to the extent of 11 and 15% of dose. After enzymic hydrolysis the urinary metabolites (derivatives of mono (2-ethylhexyl)phthalate) were methylated and identified by g.l.c.-mass spectrometry (C.I.), and the quantitative distribution of conjugated and free metabolites determined. DEHP taken by the same volunteers over a period of four days at doses of 10 mg daily gave no evidence of accumulation; 15 and 25% of the total dose was recovered in the urine.
Related Publications
P Schmid, and
C Schlatter
January 1989,
Drug metabolism reviews,
P Schmid, and
C Schlatter
January 1973,
Environmental health perspectives,
P Schmid, and
C Schlatter
March 1986,
Environmental health perspectives,
P Schmid, and
C Schlatter
April 1974,
Bulletin of environmental contamination and toxicology,
P Schmid, and
C Schlatter
January 2004,
Report on carcinogens : carcinogen profiles,
P Schmid, and
C Schlatter
April 1989,
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
P Schmid, and
C Schlatter
January 2011,
Report on carcinogens : carcinogen profiles,
P Schmid, and
C Schlatter
January 2000,
IARC monographs on the evaluation of carcinogenic risks to humans,
P Schmid, and
C Schlatter
January 2002,
Report on carcinogens : carcinogen profiles,
P Schmid, and
C Schlatter
May 1982,
IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans,
